"Anti-Inflammatory Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that reduce or suppress INFLAMMATION.
| Descriptor ID |
D000893
|
| MeSH Number(s) |
D27.505.954.158
|
| Concept/Terms |
Anti-Inflammatory Agents- Anti-Inflammatory Agents
- Anti Inflammatory Agents
- Agents, Antiinflammatory
- Antiinflammatories
- Antiinflammatory Agents
- Agents, Anti-Inflammatory
- Agents, Anti Inflammatory
- Anti-Inflammatories
- Anti Inflammatories
|
Below are MeSH descriptors whose meaning is more general than "Anti-Inflammatory Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Inflammatory Agents".
This graph shows the total number of publications written about "Anti-Inflammatory Agents" by people in this website by year, and whether "Anti-Inflammatory Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 5 | 7 |
| 1997 | 3 | 4 | 7 |
| 1998 | 6 | 0 | 6 |
| 1999 | 4 | 1 | 5 |
| 2000 | 0 | 1 | 1 |
| 2001 | 6 | 7 | 13 |
| 2002 | 3 | 3 | 6 |
| 2003 | 5 | 4 | 9 |
| 2004 | 3 | 3 | 6 |
| 2005 | 6 | 4 | 10 |
| 2006 | 5 | 4 | 9 |
| 2007 | 10 | 6 | 16 |
| 2008 | 4 | 3 | 7 |
| 2009 | 10 | 2 | 12 |
| 2010 | 7 | 6 | 13 |
| 2011 | 8 | 6 | 14 |
| 2012 | 5 | 7 | 12 |
| 2013 | 8 | 5 | 13 |
| 2014 | 11 | 5 | 16 |
| 2015 | 6 | 5 | 11 |
| 2016 | 5 | 3 | 8 |
| 2017 | 9 | 2 | 11 |
| 2018 | 7 | 6 | 13 |
| 2019 | 7 | 1 | 8 |
| 2020 | 5 | 7 | 12 |
| 2021 | 6 | 1 | 7 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Inflammatory Agents" by people in Profiles.
-
Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models. Cells. 2024 Feb 25; 13(5).
-
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024 Feb 06; 15(1):974.
-
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors. J Med Chem. 2024 02 22; 67(4):2712-2731.
-
Large-scale computational modelling of the M1 and M2 synovial macrophages in rheumatoid arthritis. NPJ Syst Biol Appl. 2024 Jan 26; 10(1):10.
-
Mechanism of TLR4-Mediated Anti-Inflammatory Response Induced by Exopolysaccharide from the Probiotic Bacillus subtilis. J Immunol. 2023 10 15; 211(8):1232-1239.
-
MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia. Acta Biomater. 2023 03 01; 158:782-797.
-
Coronavirus Disease 2019 Temperature Trajectories Correlate With Hyperinflammatory and Hypercoagulable Subphenotypes. Crit Care Med. 2022 02 01; 50(2):212-223.
-
Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res. 2022 01 29; 118(2):413-423.
-
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 01; 7(1):69-95.
-
TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. Clin Pharmacol Ther. 2022 01; 111(1):263-271.